MustGrow Commences Funded Study On Tobacco Crop Protection Program

MustGrow Biologics (CSE: MGRO) announced this morning the commencement of a tobacco crop protection research program. The program is being funded by the Canadian Tobacco Research Foundation, with the goal of targeting tobacco cyst nematodes and root-lesion nematodes.

A collaborative research program is currently underway between the foundation and MustGrow as a means of building on the firms previous achievements that include third party studies using MustGrow’s patented mustard-derived bio-pesticide that demonstrated 100% control of soil-borne diseases and pathogens that include nematodes. Corporate collaboration discussions with tobacco industry leaders are also underway.

The study will see MustGrow’s patented liquid format utilized for testing of effectiveness against the disease, whereas previous testing has largely focused on the granular product format. The use of liquid format enables the bio-pesticide to be applied via spraying, which is often a more favourable alternative for application. The product will be evaluated in both pre-planting and post-planting applications, targeting tobacco cyst nematodes after hatching.

Nematodes are parasitic worms that infect the root system of a plant, reducing water and nutrient movement within the plant and stunting growth, resulting in lower yields. Yield destruction from the parasite has been reported in eleven tobacco-producing countries, which includes both Canada and the US. Global tobacco crop loss from the parasite is estimated as being US$4.2 billion, or 15%. Nematodes continue to do this damage to tobacco plants despite the use of synthetic chemical pesticides, which continue to be deregistered or banned due to the harmful effects of such pesticides.

A timeline for the completion of the collaborative research program has not been provided, however the study is currently underway.

MustGrow Biologics last traded at $0.32 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

MustGrow Sees Executive From Impossible Foods Appointed To Board

MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed...

Monday, December 14, 2020, 07:25:26 AM

MustGrow’s Liquid Formulation To Undergo Additional Product Testing

MustGrow Biologics Corp (CSE: MGRO) is furthering its product development initiatives related to its proposed...

Thursday, February 20, 2020, 09:47:16 AM

MustGrow Biologics Sees CannaPM Approved For Use Against Powdery Mildew In Cannabis And Hemp

It appears that revenues might be coming in the near term to MustGrow Biologics (CSE:...

Wednesday, February 24, 2021, 07:11:49 AM

Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO...

Monday, December 21, 2020, 01:00:00 PM

MustGrow: Organic Disease Control – The Daily Dive

Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow...

Monday, August 30, 2021, 01:30:00 PM